
Organization · Venture Capital
Pontifax Venture Capital
Pontifax Venture Capital is a healthcare-focused venture capital firm based in the United States, managing $1.2 billion in assets. It invests in transformative life sciences technologies across all development stages.
Overview
What Pontifax Venture Capital does
What Pontifax Venture Capital is
Pontifax Venture Capital is a healthcare-focused venture capital firm based in the United States, managing $1.2 billion in assets. It invests in transformative life sciences technologies across all development stages.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2004
- Approximate age
- About 22 years
- Structured capabilities
- Funder
- Last reviewed
- March 18, 2026
Official channels
Find Pontifax Venture Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Pontifax Venture Capital as a funder
Investment thesis
Pontifax Venture Capital focuses on transformative life sciences technologies across all development stages, investing in breakthrough innovations regardless of therapeutic area.
Focus narrative
Pontifax invests in breakthrough innovations in life sciences, regardless of therapeutic area or development stage. The firm is involved in sourcing disruptive ideas, building companies, and providing hands-on guidance to maximize success. It invests in clinical-stage companies and offers strategic direction, capital markets expertise, and mergers and acquisitions support.
Value beyond capital
Pontifax provides strategic direction, capital markets expertise, and mergers and acquisitions support to its portfolio companies, ensuring they maximize their potential for success.
Focus and fit
- Stages
- Friends and Family · Angel · Accelerator · Pre-seed · Seed · Seed+ · Series A · Series A+ · Series B · Series B+ · Series C · Series C+ · Series D · Series E · Series F · Growth Equity · Pre-IPO · Ipo
- Regions
- Asia · Europe · Global · North America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 100
Portfolio context
Pontifax's portfolio includes approximately 100 companies that develop solutions to significant unmet needs in the healthcare sector. Specific names and descriptions of notable portfolio companies were not provided.
Connected ecosystem
Continue from Pontifax Venture Capital
These links use structured organization type, sector, and regional relationships. They do not imply endorsement or commercial similarity.
Same organization type
Structured sector focus
Structured regional focus
Common questions
What to know about Pontifax Venture Capital
Upseed classifies Pontifax Venture Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 18, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.